Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Stomach Neoplasms × ARQ 197 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 3 Solid Tumors 2 Mesothelioma, Malignant 2 Melanoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Solid Neoplasm 1 Seminoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Renal Insufficiency 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteolysis 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Malignant Solid Tumour 1 Liver Neoplasms 1 Hypercalcemia 1 Hematologic Neoplasms 1 Fractures, Spontaneous 1

Interventions

Oxaliplatin 267 Capecitabine 187 Fluorouracil 165 Cisplatin 149 Docetaxel 124 S 1 (combination) 121 Paclitaxel 112 Leucovorin 109 Irinotecan 98 pembrolizumab 90 Trastuzumab 61 apatinib 54 Nivolumab 50 Drug Therapy 40 sintilimab 38 Radiotherapy 36 Surgical Procedures, Operative 35 Bevacizumab 34 Ramucirumab 32 Carboplatin 30 titanium silicide 27 tislelizumab 27 Hyperthermic Intraperitoneal Chemotherapy 27 Epirubicin 27 Cyclophosphamide 24 XELOX 23 Tegafur 22 camrelizumab 19 Folfox protocol 19 Cetuximab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01152645 2017-03-15

ARQ 197-004

Kyowa Kirin Co., Ltd.

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡